Pelosi also said it's "irrelevant" whether approving the USMCA trade deal would give President Donald Trump a victory ahead of the 2020 election.Politicsread more
Brent crude oil jumped the most in history in the previous session after attacks on Saudi's oil industry disrupted the kingdom's production.Marketsread more
General Motors stands to lose hundreds of millions of dollars in lost production as a United Auto Workers union strike against the automaker enters its second day, but Wall...Autosread more
Damage to the top OPEC producer's oil facilities ignited fears of supply disruption around the world and has sent crude prices soaring.Energyread more
The second-largest investor in Kraft Heinz Company discloses that it has again trimmed its stake in the food company.Marketsread more
"That leads the developed world to say to China: 'We've got to rebalance this. It's working for you. It's not working for us,'" says the billionaire Blackstone co-founder.Economyread more
Microsoft founder Bill Gates takes an aggressive approach to investing, despite being the second richest person in the world.Wealthread more
Viacom chief executive officer Bob Bakish is not worried about competition in the streaming space, on the heels of its merger with CBS.The Faber Reportread more
Consumers could pay an average 15 to 20 cents more per gallon for unleaded gas by the end of the month following the attack on Saudi oil installations.Market Insiderread more
Bob Bakish, the head of a newly combined CBS and Viacom, said he was "disappointed" by both stocks' reaction to the recent deal.The Faber Reportread more
Elliott Management may not see John Stankey as a future leader at AT&T, but bailing on him before he executes his integration plan has the potential for disaster.Technologyread more
In trading the biotechnology sector, investors should buy funds rather than individual stocks to hedge against uncertainty, CNBC "Fast Money" trader Steve Grasso said.
He looked to the iShares Nasdaq Biotechnology ETF, which includes many of the sector's strongest performers.
"Instead of worrying about these single stock stories that are binary events, you buy IBB. You probably sleep a little bit better at night," he said.
The exchange-traded fund has jumped more than 16 percent this year. It rose 0.3 percent on Thursday, closing around $353 per share.
Isis Pharmaceuticals—which spiked 3 percent on Thursday—could make a strong long play, trader Guy Adami said.
Jon Najarian is long ABT, ADBE, ADP, ADT, AN, ATVI, AVP, BBY, BSX, EQT, EXXI, HUN, INFN, LL, MNST, MRVL, MW, NEE, NOK, NRG, NSAM, OAS, POST, RHT, RKUS, SCTY, SIRI, SOL, SYK, TEVA, TTWO, TWX, WMB, XLI, XPO and ZIOP. He is long calls AKS, APD, BABA, BBY, EQT, EWJ, GRPN, IDTI, MET, MNST, MYL, NTAP, PPC, PRU, RAD, RKUS, SAP, SNDK, TAP, TWX, XPO and ZIOP. Today, he bought XPO calls, AVP, XLI and XPO.
Steve Grasso is long AAPL, EVGN, MJNA, PFE, T, TWTR and GDX. His firm is long AVP, AMD, IBM, ZNGA. His kids own EFG, EFA, EWJ, IJR and SPY.
Brian Kelly is long BTC=, U.S. dollar, GLD, EEM, CTRL calls, GSG, BBRY, SPY puts, TLT, 30-year bond futures. He is short yuan.
Guy Adami is long CELG, EXAS and INTC. Guy Adami's wife, Linda Snow, works at Merck.